Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-14

Clinical Trial Update: Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update evaluating the safety and efficacy of Gentamicin topical gel (AppliGel-G) for mild to moderately infected diabetic foot ulcers in Phase 1 …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AppliGel-G (Gentamicin topical gel)

Snippet

Sponsor: Royer Biomedical, Inc. | Conditions: Diabetic Foot Ulcers | Phase 1, Phase 2 | Status: TERMINATED